Literature DB >> 9818540

Novel human immunodeficiencies reveal the essential role of type-I cytokines in immunity to intracellular bacteria.

T H Ottenhoff1, D Kumararatne, J L Casanova.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9818540     DOI: 10.1016/s0167-5699(98)01321-8

Source DB:  PubMed          Journal:  Immunol Today        ISSN: 0167-5699


× No keyword cloud information.
  95 in total

Review 1.  Partners in crime: co-infections in the developing world.

Authors:  A Pennycook; P Openshaw; T Hussell
Journal:  Clin Exp Immunol       Date:  2000-12       Impact factor: 4.330

Review 2.  Tuberculosis: latency and reactivation.

Authors:  J L Flynn; J Chan
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

Review 3.  The many faces of host responses to tuberculosis.

Authors:  H L Collins; S H Kaufmann
Journal:  Immunology       Date:  2001-05       Impact factor: 7.397

Review 4.  Serological markers of disease activity in tuberculosis and HIV infection.

Authors:  A Marchant
Journal:  Clin Exp Immunol       Date:  2000-10       Impact factor: 4.330

Review 5.  Immune regulatory activities of early secreted antigenic target of 6-kD protein of Mycobacterium tuberculosis and implications for tuberculosis vaccine design.

Authors:  Buka Samten; Xisheng Wang; Peter F Barnes
Journal:  Tuberculosis (Edinb)       Date:  2011-12-09       Impact factor: 3.131

6.  Cytokine polarization in miliary and pleural tuberculosis.

Authors:  Surendra K Sharma; Dipender K Mitra; Arumugam Balamurugan; Ravindra M Pandey; Narinder K Mehra
Journal:  J Clin Immunol       Date:  2002-11       Impact factor: 8.317

7.  Suppressed type 1, type 2, and type 17 cytokine responses in active tuberculosis in children.

Authors:  N Pavan Kumar; R Anuradha; R Suresh; R Ganesh; Janani Shankar; V Kumaraswami; Thomas B Nutman; Subash Babu
Journal:  Clin Vaccine Immunol       Date:  2011-09-28

8.  Bystander activation of CD8+ T lymphocytes during experimental mycobacterial infection.

Authors:  Brad Gilbertson; Susie Germano; Pauline Steele; Steven Turner; Barbara Fazekas de St Groth; Christina Cheers
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

Review 9.  Striking the right immunological balance prevents progression of tuberculosis.

Authors:  Shachi Pranjal Vyas; Ritobrata Goswami
Journal:  Inflamm Res       Date:  2017-07-15       Impact factor: 4.575

10.  Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cells.

Authors:  Thomas J Scriba; Michele Tameris; Nazma Mansoor; Erica Smit; Linda van der Merwe; Fatima Isaacs; Alana Keyser; Sizulu Moyo; Nathaniel Brittain; Alison Lawrie; Sebastian Gelderbloem; Ashley Veldsman; Mark Hatherill; Anthony Hawkridge; Adrian V S Hill; Gregory D Hussey; Hassan Mahomed; Helen McShane; Willem A Hanekom
Journal:  Eur J Immunol       Date:  2010-01       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.